Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 8:38 PM View:  | Travere Therapeutics, Inc. (TVTX) | 30-Sep-24 | Option Exercise | 40,000 | $10.48 | $419,200.00 | 49% 81.0K to 121.0K | |
| 30-Sep-24 8:38 PM View: | Travere Therapeutics, Inc. (TVTX) | 30-Sep-24 | Planned Option Sale | 40,000 | $14.06 | $562,324.00 | (33%) 121.0K to 81.0K | |
| 08-Aug-24 5:30 PM View: | Indaptus Therapeutics, Inc. (INDP) | 08-Aug-24 | Grant | 84,932 | $1.83 | $155,001.00 | 113% 75.37K to 160.31K | |
| 10-May-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-24 | Grant | 6,500 | -- | -- | 9% 74.5K to 81.0K | |
| 19-May-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-23 | Grant | 4,500 | -- | -- | 6% 70.0K to 74.5K | |
| 22-Nov-22 8:00 AM View: | Indaptus Therapeutics, Inc. (INDP) | 21-Nov-22 | Purchase | 9,600 | $1.90 | $18,240.00 | 15% 65.77K to 75.37K | |
| 22-Nov-22 8:00 AM View: | Indaptus Therapeutics, Inc. (INDP) | 18-Nov-22 | Private Purchase | 400 | $1.76 | $705.48 | < 1% 65.37K to 65.77K | |
| 12-Sep-22 9:00 AM View: | Indaptus Therapeutics, Inc. (INDP) | 08-Sep-22 | Private Purchase | 10,308 | $2.80 | $28,862.40 | 19% 55.07K to 65.37K | |
| 08-Sep-22 9:00 AM View: | Indaptus Therapeutics, Inc. (INDP) | 07-Sep-22 | Purchase | 8,632 | $2.57 | $22,184.20 | 19% 46.43K to 55.07K | |
| 08-Sep-22 9:00 AM View: | Indaptus Therapeutics, Inc. (INDP) | 06-Sep-22 | Private Purchase | 1,060 | $2.44 | $2,586.40 | 2% 45.37K to 46.43K | |
| 07-Jun-22 8:00 AM View: | Indaptus Therapeutics, Inc. (INDP) | 06-Jun-22 | Private Purchase | 19,727 | $2.63 | $51,882.00 | 77% 25.65K to 45.37K | |
| 12-May-22 8:26 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Grant | 3,000 | -- | -- | 4% 67.0K to 70.0K | |
| 19-Nov-21 9:16 AM View: | Indaptus Therapeutics, Inc. (INDP) | 18-Nov-21 | Market Purchase | 11,187 | $5.82 | $65,108.30 | 77% 14.46K to 25.65K | |
| 16-Sep-21 6:22 PM View: | Indaptus Therapeutics, Inc. (INDP) | 14-Sep-21 | Market Purchase | 12,000 | $7.00 | $84,000.00 | 488% 2.46K to 14.46K | 54% |
| 18-May-21 9:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-21 | Grant | 3,000 | -- | -- | 5% 64.0K to 67.0K | |
| 19-May-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-20 | Grant | 3,000 | -- | -- | 5% 61.0K to 64.0K | |
| 29-Aug-19 4:16 PM View: | Intec Pharma Ltd. (NTEC) | 28-Aug-19 | Market Purchase | 20,000 | $0.68 | $13,620.00 | 11% 176.76K to 196.76K | (80%) |
| 27-Aug-19 4:18 PM View: | Intec Pharma Ltd. (NTEC) | 23-Aug-19 | Market Purchase | 100,000 | $0.46 | $45,700.00 | 130% 76.76K to 176.76K | (70%) |
| 10-May-19 8:37 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-19 | Grant | 2,000 | -- | -- | 3% 59.0K to 61.0K | |
| 11-May-18 9:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-18 | Grant | 2,500 | -- | -- | 4% 56.5K to 59.0K | |
| 18-May-17 6:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-17 | Grant | 2,500 | -- | -- | 5% 54.0K to 56.5K | |
| 19-May-16 1:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-May-16 | Grant | 2,000 | -- | -- | 4% 52.0K to 54.0K | |
| 17-Mar-16 4:05 PM View: | Cocrystal Pharma, Inc. (COCP) | 15-Mar-16 | Private Purchase | 294,118 | $0.51 | $150,000.00 | 81% 363.04K to 657.16K | |
| 07-Mar-16 8:50 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Mar-16 | Market Purchase | 5,000 | $15.31 | $76,564.50 | 11% 47.0K to 52.0K | (3%) |
| 03-Mar-16 6:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Mar-16 | Market Purchase | 10,000 | $14.45 | $144,500.00 | 27% 37.0K to 47.0K | 7% |
| 28-Dec-15 4:05 PM View: | Cocrystal Pharma, Inc. (COCP) | 23-Dec-15 | Market Purchase | 100,000 | $0.58 | $57,870.00 | 38% 263.04K to 363.04K | (91%) |
| 01-Jul-15 4:03 PM View: | QLT Inc. (NVLNF) | 29-Jun-15 | Option Exercise | 25,000 | $3.48 | $87,125.00 | 30% 82.0K to 107.0K | |
| 10-Jun-15 2:02 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Jun-15 | Grant | 2,000 | -- | -- | 6% 35.0K to 37.0K | |
| 09-Jun-15 9:00 PM View: | QLT Inc. (NVLNF) | 07-Jun-15 | Option Exercise | 10,000 | -- | -- | 14% 72.0K to 82.0K | |
| 27-Mar-15 4:16 PM View: | Cocrystal Pharma, Inc. (COCP) | 25-Mar-15 | Purchase | 163,043 | $0.92 | $150,000.00 | 163% 100.0K to 263.04K | |
| 19-Dec-14 2:13 PM View: | QLT Inc. (NVLNF) | 18-Dec-14 | Market Purchase | 20,000 | $3.60 | $72,000.00 | 38% 52.0K to 72.0K | (49%) |
| 17-Dec-14 3:10 PM View: | QLT Inc. (NVLNF) | 15-Dec-14 | Option Exercise | 2,000 | -- | -- | 4% 50.0K to 52.0K | |
| 15-Dec-14 4:17 PM View: | Cocrystal Pharma, Inc. (COCP) | 11-Dec-14 | Purchase | 100,000 | $0.46 | $45,610.00 | 100% 0 to 100.0K | |
| 25-Nov-14 3:16 PM View: | Travere Therapeutics, Inc. (TVTX) | 25-Nov-14 | Market Purchase | 15,000 | $8.60 | $129,050.00 | 75% 20.0K to 35.0K | < 1% |
| 10-Oct-14 4:55 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Oct-14 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 01-Jul-13 2:29 PM View: | QLT Inc. (NVLNF) | 28-Jun-13 | Market Purchase | 30,000 | $4.36 | $130,800.00 | 150% 20.0K to 50.0K | (58%) |
| 06-May-13 3:41 PM View: | QLT Inc. (NVLNF) | 03-May-13 | Market Purchase | 20,000 | $7.96 | $159,200.00 | 100% 0 to 20.0K | (56%) |